ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 354462 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 354462; 2) Community: the network communities that were significantly associated with the response to NSC 354462; 3) Molecule: the relationships between components within communities and NSC 354462; 4) MDR: the compounds that were significantly associated with the NSC 354462.

NSC Compound Enrichment Correlation
NSC 671134 Null 0.0138010872611484 0.096763077
NSC 683086 Boronic acid, [3-methyl-1-[[1-oxo-4-phenyl- 2-[[(2-quinolinyl)carbonyl]amino]butyl]amino]butyl]- 0.0138010872611484 0.47434845
NSC 684481 7H-Pyrido[3,2-d][1]benzazepine-6-thione, 2-(3-chloro- phenyl)-5,6-dihydro-4-phenyl- 0.0138010872611484 -0.2645055
NSC 701314 1H,3H-Thiazolo[3,4-a]benzimidazole, 1-(2,6-dichlorophenyl)-6-methoxy- 0.0138010872611484 0.2545437
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0138010872611484 0.25962289
NSC 733504 Everolimus 0.0138010872611484 -0.41955299
NSC 176098 Phosphonium, methyl[2-methyl-2-(4-methylphenyl)propyl]diphenyl-, iodide 0.0138010872611486 0.4207922
NSC 189793 Streptovaricin complex, fraction a 0.0138010872611486 0.22531113
NSC 295500 Camptothecin Derivative 0.0138010872611486 -0.21037645
NSC 163949 3,6-Diamino-10-methylacridinium chloride hydrochloride 0.0149636429145595 -0.16240926
Total:37  Current:10    [First] [Prev] [Next] [Last]